Post-transplantation lymphoproliferative disorder in pediatric kidney-transplant recipients - A national study

Pediatric Transplantation

Volumn 16, Issue 6, 2012, Pages 619-626

  Cleper, Roxana ^a,b,c   Ben Shalom, Efrat ^d,e   Landau, Daniel ^f,g   Weissman, Irith ^h   Krause, Irit ^a,b   Konen, Osnat ^a,b   Rahamimov, Ruth ^b,i   Mor, Eytan ^b,i   Bar Nathan, Nathan ^b,i   Frishberg, Yaakov ^d,e   Davidovits, Miriam ^a,b  

^a SCHNEIDER CHILDREN S MEDICAL CENTER OF ISRAEL   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^d SHAARE ZEDEK MEDICAL CENTER   (Israel)

^e HEBREW UNIVERSITY   (Israel)

^f BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^g BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^h WESTERN GALILEE HOSPITAL   (Israel)

ⁱ RABIN MEDICAL CENTER   (Israel)

Author keywords

EBV; kidney transplantation; outcome; pediatric; post transplantation lymphoproliferative disorder

Indexed keywords

ACICLOVIR; CD20 ANTIBODY; MONOCLONAL ANTIBODY; OKT 3; VALGANCICLOVIR;

ACUTE GRAFT REJECTION; ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DIALYSIS; FEMALE; GRAFT DYSFUNCTION; GRAFT RECIPIENT; GRAFT SURVIVAL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY GRAFT; KIDNEY TRANSPLANTATION; MALE; MORTALITY; POSTOPERATIVE COMPLICATION; POSTTRANSPLANT LYMPHOPROLIFERATIVE DISEASE; PREVALENCE; SCHOOL CHILD;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFANT; ISRAEL; KIDNEY TRANSPLANTATION; LYMPHOPROLIFERATIVE DISORDERS; MALE; PEDIATRICS; POSTOPERATIVE PERIOD; PREVALENCE; REGISTRIES; RENAL INSUFFICIENCY; RISK; T-LYMPHOCYTES; TIME FACTORS; TREATMENT OUTCOME;

EID: 84864577113     PISSN: 13973142     EISSN: 13993046     Source Type: Journal    
DOI: 10.1111/j.1399-3046.2012.01731.x     Document Type: Article

References (35)

1. Warady BA, Chadha V,. Chronic kidney disease in children: The global perspective. Pediatr Nephrol 2007: 22: 1999-2009. (Pubitemid 350090707)
2. Fishman JA,. Infection in solid-organ transplant recipients. N Engl J Med 2007: 357: 2601-2614. (Pubitemid 350294226)
3. Penn I,. De novo malignancies in pediatric organ transplant recipients. Pediatr Transplant 1998: 2: 56-63. (Pubitemid 128655464)
4. Dharnidharka VR, Araya CE,. Post-transplant lymphoproliferative disease. Pediatr Nephrol 2009: 24: 731-736.
5. N orth A merican P ediatric R enal T ransplant C ooperative S tudies (NAPRTCS). 2010 Annual Report. Available at: (accessed June 16, 2011).
6. Bustami RT, Ojo AO, Wolfe RA, et al., Immunosuppression and the risk of post-transplant malignancy among cadaveric first kidney transplant recipients. Am J Transplant 2004: 4: 87-93. (Pubitemid 38155493)
7. Caillard S, Dharnidharka V, Agodoa L, et al., Posttransplant lymphoproliferative disorders after renal transplantation in the United States in era of modern immunosuppression. Transplantation 2005: 80: 1233-1243. (Pubitemid 41746802)
8. Kasiske BL, Snyder JJ, Gilbertson DT, Wang C,. Cancer after kidney transplantation in the United States. Am J Transplant 2004: 4: 905-913. (Pubitemid 38745589)
9. Swerdlow SH, Webber SA, Chadbum A, et al., Post-Transplant Lymphoproliferative Disorders. WHO Classification of Tumours of Hematopoietic and Lymphoid Tissues. Lyon: IARC Press, 2008.
10. Lim WH, Russ GR, Coates PTH,. Review of Epstein-Barr virus and post-transplant lymphoproliferative disorder post-solid organ transplantation. Nephrology 2006: 11: 355-366. (Pubitemid 44086882)
11. Holmes RD, Sokol RJ,. Epstein-Barr virus and the post-transplant lymphoproliferative disease. Pediatr Transplant 2002: 6: 456-464. (Pubitemid 35470542)
12. Dantal J, Pohanka E,. Malignancies in renal transplantation: An unmet medical need. Nephrol Dial Transplant 2007: 22 (Suppl 1): i4-i10. (Pubitemid 47073738)
13. Smith JM, Rudser K, Gillen D, et al., Risk of lymphoma after renal transplantation varies with time: An analysis of the United States Renal Data System. Transplantation 2006: 81: 175-180.
14. Grenda R, Watson A, Trompeter R, et al., A randomized trial to assess the impact of early steroid withdrawal on growth in pediatric renal transplantation: The TWIST study. Am J Transplant 2010: 10: 828-836.
15. Kapelushnik J, Ariad S, Benharroch D, et al., Post renal transplantation human herpesvirus 8-associated lymphoproliferative disorder and Kaposi sarcoma. Br J Haematol 2001: 113: 425-428. (Pubitemid 32523148)
16. Dharnidharka VR, Sullivan EK, Stablein DM, et al., Risk factors for posttransplant lymphoproliferative disorder (PTLD) in pediatric kidney transplantation: A report of the North American Pediatric Renal transplant Cooperative Study (NAPRTCS). Transplantation 2001: 71: 1065-1068. (Pubitemid 32448820)
17. Opelz G, Dohler B,. Lymphomas after solid organ transplantation: A collaborative transplant study report. Am J Transplant 2004: 4: 222-230. (Pubitemid 38248525)
18. Swinnen LJ, Costanzo-Nordin MR, Fisher SG, et al., Increased incidence of lymphoproliferative disorder after immunosuppression with monoclonal antibody OKT3 in cardiac-transplant recipients. N Engl J Med 1990: 323: 1723-1728.
19. Webster A, Woodroffe RC, Taylor RS, et al., Tacrolimus versus cyclosporine as primary immunosuppression for kidney transplant recipients. Cochrane Database Syst Rev 2005: 4: CD003961.
20. Dharnidharka VR, Talley LI, Martz KL, et al., Recombinant growth hormone use pretransplant and risk for post-transplant lymphoproliferative disease-a report of the NAPRTCS. Pediatr Transplantation 2008: 12: 689-695.
21. Allen UD, Farkas G, Hebert D, et al., Risk factors for post-transplant lymphoproliferative disorder in pediatric patients: A case-control study. Pediatr Transplant 2005: 9: 450-455. (Pubitemid 41153264)
22. Funch D, Walker A, Schneider G, Ziyadeh N, Pescovitz M,. Ganciclovir and acyclovir reduce the risk of post-transplant lymphoproliferative disorder in renal transplant recipients. Am J Transplant 2005: 5: 2894-2900. (Pubitemid 43923949)
23. Wilde GE, Moore DJ, Bellah RD,. Posttransplantation lymphoproliferative disorder in pediatric recipients of solid organ transplants: Timing and location of disease. Am J Radiol 2005: 185: 1335-1341.
24. Bakker NA, Van Imhoff GW, Verschuuren EAM, Van Son WJ,. Presentation and early detection of post-transplant lymphoproliferative disorder after solid organ transplantation. Transplant Int 2007: 20: 207-218.
25. Trofe J, Buell JF, Beebe TM, et al., Analysis of factors that influence survival with post-transplant lymphoproliferative disorder in renal transplant recipients: The Israel Penn International Transplant Tumor Registry experience. Am J Transplant 2005: 5: 775-780. (Pubitemid 40461287)
26. McDonald RA, Smith JM, Ho M, et al., and the CCTPT S tudy G roup. Incidence of PTLD in pediatric renal transplant recipients receiving basiliximab, calcineurin inhibitor, sirolimus and steroids. Am J Transplant 2008: 8: 984-989. (Pubitemid 351537758)
27. Maeker B, Jack T, Zimmermann M, et al., CNS or bone marrow involvement as risk factors for poor survival in post-transplantation lymphoproliferative disorders in children after solid organ transplantation. J Clin Oncol 2007: 25: 4902-4908. (Pubitemid 350220420)
28. Afify Z,. T-cell post-transplantation lymphoproliferative disorder, a rare and challenging late complication of solid organ transplantation. Pediatr Transplant 2008: 12: 617-618.
29. Yang F, Li Y, Braylan R, Hunger S, Yang L-J,. Pediatric T-cell post-transplant lymphoproliferative disorder after solid organ transplantation. Pediatr Blood Cancer 2008: 50: 415-418.
30. Moosa MR,. Kaposi's sarcoma in kidney transplant recipients: A 23-year experience. Q J Med 2005: 98: 205-214. (Pubitemid 40361318)
31. Buell JF, Gross TG, Hanaway MJ, et al., Chemotherapy for posttransplant lymphoproliferative disorder: The Israel Penn International Tumor Registry experience. Transplant Proc 2005: 37: 956-957. (Pubitemid 40590757)
32. Gupta S, Fricker FJ, Gonzalez-Peralta RP, et al., Post-transplant lymphoproliferative disorder in children: Recent outcomes and response to dual rituximab/low dose chemotherapy combination. Pediatr Transplant 2010: 14: 896-902.
33. Dharnidharka VR, Gupta S,. Reducing the chemotherapy burden through addition of rituximab. Pediatr Transplant 2010: 14: 10-11.
34. Dharnidharka VR, Martz KL, Stablein DM, Benfield MR,. Improved survival with recent post-transplant lymphoproliferative disorder (PTLD) in children with kidney transplants. Am J Transplant 2011: 11: 751-758.
35. Smith JM, Corey L, Healey PJ, et al., Adolescents are more likely to develop posttransplant lymphoproliferative disorder after primary Epstein-Barr virus infection than younger renal transplant recipients. Transplantation 2007: 83: 1423-1428. (Pubitemid 46934064)